| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7860280 | Journal of Controlled Release | 2018 | 34 Pages |
Abstract
Mesoporous silicon microparticles enabled co-delivery of tumor antigen and dual toll-like receptor ligands provide rational and potentially translational approach to develop durable and potent immunotherapy against cancer.252
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Motao Zhu, Xilai Ding, Ruifang Zhao, Xuewu Liu, Haifa Shen, Chunmei Cai, Mauro Ferrari, Helen Y. Wang, Rong-Fu Wang,